The University of Chicago Header Logo

Connection

Larry Kociolek to Child

Back to Details
This is a "connection" page, showing publications Larry Kociolek has written about Child.
Larry Kociolek
Connection Strength
3.068
Child
  1. Clostridioides difficile in Children. Infect Dis Clin North Am. 2025 Dec; 39(4):709-725.
    View in: PubMed
    Score: 0.098
  2. Impact of universal masking by pediatric healthcare personnel on non-SARS-CoV-2 healthcare-associated viral respiratory infections: A quasi-experimental study. Am J Infect Control. 2025 06; 53(6):735-738.
    View in: PubMed
    Score: 0.096
  3. Infection Prevention and Control Implications of Special Pathogens in Children. Pediatr Clin North Am. 2024 06; 71(3):431-454.
    View in: PubMed
    Score: 0.089
  4. Association Between Clostridium innocuum and Antibiotic-Associated Diarrhea in Adults and Children: A Cross-sectional Study and Comparative Genomics Analysis. Clin Infect Dis. 2023 02 08; 76(3):e1244-e1251.
    View in: PubMed
    Score: 0.083
  5. Implementation of a Structured Process for Clinically Indicated Testing for Clostridioides difficile Infections in Pediatric Oncology and Stem Cell Transplant. J Pediatr Hematol Oncol Nurs. 2023 May-Jun; 40(3):188-194.
    View in: PubMed
    Score: 0.083
  6. Severity of Illness Caused by Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern in Children: A Single-Center Retrospective Cohort Study. J Pediatric Infect Dis Soc. 2022 Oct 25; 11(10):440-447.
    View in: PubMed
    Score: 0.081
  7. Incidence and Clinical Characteristics of Severe Acute Respiratory Syndrome Coronavirus 2 Infection After Vaccination in Children. J Pediatr. 2022 12; 251:196-201.e4.
    View in: PubMed
    Score: 0.080
  8. Identification of Clostridium innocuum hypothetical protein that is cross-reactive with C. difficile anti-toxin antibodies. Anaerobe. 2022 Jun; 75:102555.
    View in: PubMed
    Score: 0.078
  9. Translational Aspects of the Immunology of Clostridioides difficile Infection: Implications for Pediatric Populations. J Pediatric Infect Dis Soc. 2021 Nov 17; 10(Supplement_3):S8-S15.
    View in: PubMed
    Score: 0.076
  10. Clostridioides difficile Infection in Children: Research Progress, Pitfalls, and Priorities. J Pediatric Infect Dis Soc. 2021 Nov 17; 10(Supplement_3):S1-S2.
    View in: PubMed
    Score: 0.076
  11. Recent advances in Clostridioides difficile infection epidemiology, diagnosis and treatment in children. Curr Opin Infect Dis. 2021 10 01; 34(5):527-532.
    View in: PubMed
    Score: 0.075
  12. Viral whole-genome sequencing to assess impact of universal masking on SARS-CoV-2 transmission among pediatric healthcare workers. Infect Control Hosp Epidemiol. 2022 10; 43(10):1408-1412.
    View in: PubMed
    Score: 0.075
  13. Viral Loads of SARS-CoV-2 in Young Children-Reply. JAMA Pediatr. 2021 05 01; 175(5):530-531.
    View in: PubMed
    Score: 0.073
  14. Impact of an automated multiple emitter whole-room ultraviolet-C disinfection system on hospital acquired infections: A quasi-experimental study. Am J Infect Control. 2021 09; 49(9):1200-1203.
    View in: PubMed
    Score: 0.073
  15. Moving the Needle on Clostridioides difficile Research in Children: A Major Step Forward but Challenges Remain. Clin Infect Dis. 2020 12 17; 71(10):2589-2591.
    View in: PubMed
    Score: 0.071
  16. Comparison of Upper Respiratory Viral Load Distributions in Asymptomatic and Symptomatic Children Diagnosed with SARS-CoV-2 Infection in Pediatric Hospital Testing Programs. J Clin Microbiol. 2020 12 17; 59(1).
    View in: PubMed
    Score: 0.071
  17. Severe Acute Respiratory Syndrome Coronavirus 2 Point Prevalence Among Asymptomatic Hospitalized Children and Subsequent Healthcare Worker Evaluation. J Pediatric Infect Dis Soc. 2020 Nov 10; 9(5):617-619.
    View in: PubMed
    Score: 0.071
  18. Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19). JAMA Pediatr. 2020 09 01; 174(9):902-903.
    View in: PubMed
    Score: 0.070
  19. Association Between Children's Hospital Visitor Restrictions and Healthcare-Associated Viral Respiratory Infections: A Quasi-Experimental Study. J Pediatric Infect Dis Soc. 2020 Apr 30; 9(2):240-243.
    View in: PubMed
    Score: 0.068
  20. Clostridioides difficile Whole-Genome Sequencing Reveals Limited Within-Host Genetic Diversity in a Pediatric Cohort. J Clin Microbiol. 2019 09; 57(9).
    View in: PubMed
    Score: 0.065
  21. Risk factors for Clostridioides (Clostridium) difficile infection following solid organ transplantation in children. Transpl Infect Dis. 2019 Oct; 21(5):e13149.
    View in: PubMed
    Score: 0.065
  22. Response to: Treatment of (Recurrent) Clostridioides difficile Infections in Children and Adults. J Pediatr Gastroenterol Nutr. 2019 08; 69(2):e58-e59.
    View in: PubMed
    Score: 0.065
  23. Lack of false-positive results for Clostridioides difficile toxins A and B using two commercial enzyme immunoassays in pediatric patients. Infect Control Hosp Epidemiol. 2019 07; 40(7):825-826.
    View in: PubMed
    Score: 0.064
  24. Healthcare provider diagnostic testing practices for identification of Clostridioides (Clostridium) difficile in children: an Emerging Infections Network survey. Infect Control Hosp Epidemiol. 2019 03; 40(3):276-280.
    View in: PubMed
    Score: 0.063
  25. Clostridium difficile Whole Genome Sequencing Reveals Limited Transmission Among Symptomatic Children: A Single-Center Analysis. Clin Infect Dis. 2018 07 02; 67(2):229-234.
    View in: PubMed
    Score: 0.060
  26. Whole-genome analysis reveals the evolution and transmission of an MDR DH/NAP11/106 Clostridium difficile clone in a paediatric hospital. J Antimicrob Chemother. 2018 05 01; 73(5):1222-1229.
    View in: PubMed
    Score: 0.059
  27. Comparative genomics analysis of Clostridium difficile epidemic strain DH/NAP11/106. Microbes Infect. 2018 04; 20(4):245-253.
    View in: PubMed
    Score: 0.058
  28. Clostridium difficile infection and commonly used pediatric medications. J Pediatr. 2017 11; 190:287-290.
    View in: PubMed
    Score: 0.057
  29. Impact of a Healthcare Provider Educational Intervention on Frequency of Clostridium difficile Polymerase Chain Reaction Testing in Children: A Segmented Regression Analysis. J Pediatric Infect Dis Soc. 2017 Jun 01; 6(2):142-148.
    View in: PubMed
    Score: 0.056
  30. Clinical and Microbiologic Assessment of Cases of Pediatric Community-associated Clostridium difficile Infection Reveals Opportunities for Improved Testing Decisions. Pediatr Infect Dis J. 2016 Feb; 35(2):157-61.
    View in: PubMed
    Score: 0.051
  31. Risk Factors for Recurrent Clostridium difficile Infection in Children: A Nested Case-Control Study. J Pediatr. 2015 Aug; 167(2):384-9.
    View in: PubMed
    Score: 0.048
  32. Molecular epidemiology of Clostridium difficile infections in children: a retrospective cohort study. Infect Control Hosp Epidemiol. 2015 Apr; 36(4):445-51.
    View in: PubMed
    Score: 0.048
  33. Concomitant Medical Conditions and Therapies Preclude Accurate Classification of Children With Severe or Severe Complicated Clostridium difficile Infection. J Pediatric Infect Dis Soc. 2015 Dec; 4(4):e139-42.
    View in: PubMed
    Score: 0.047
  34. National variability in surveillance, testing, and infection prevention for Clostridium difficile infection in pediatric populations. Am J Infect Control. 2013 Oct; 41(10):933-5.
    View in: PubMed
    Score: 0.042
  35. Cost of a Measles Outbreak in an Urban Shelter. JAMA Netw Open. 2026 Sep 01; 9(9):e2635328.
    View in: PubMed
    Score: 0.027
  36. Identification of Streptococcus pyogenes isolates with reduced beta-lactam susceptibility in a cohort of children with pharyngitis. Antimicrob Agents Chemother. 2026 07; 70(7):e0035426.
    View in: PubMed
    Score: 0.026
  37. Pediatric Infectious Diseases Physicians' Preferences for Management of Clostridioides difficile Infection: An Emerging Infections Network Survey. J Pediatric Infect Dis Soc. 2026 Jan 17; 15(1).
    View in: PubMed
    Score: 0.025
  38. Scheffersomyces spartinae Fungemia among Pediatric Patients, Pakistan, 2020-2024. Emerg Infect Dis. 2025 Aug; 31(8):1550-1560.
    View in: PubMed
    Score: 0.025
  39. Bacteremia in Pediatric Solid Organ Transplant Recipients within 1 Year of Transplant. Transpl Infect Dis. 2025 Jul-Aug; 27(4):e70030.
    View in: PubMed
    Score: 0.024
  40. Outcomes Associated with Healthcare-Associated Respiratory Syncytial Virus in Children's Hospitals. J Pediatric Infect Dis Soc. 2024 Nov 27; 13(11):594-598.
    View in: PubMed
    Score: 0.023
  41. SHEA practice update: infection prevention and control (IPC) in residential facilities for pediatric patients and their families. Infect Control Hosp Epidemiol. 2025 01; 46(1):3-26.
    View in: PubMed
    Score: 0.023
  42. Children's Hospital Resource Utilization During the 2022 Viral Respiratory Surge. Pediatrics. 2024 07 01; 154(1).
    View in: PubMed
    Score: 0.023
  43. Resurgence of SARS-CoV-2 Delta after Omicron variant superinfection in an immunocompromised pediatric patient. Virol J. 2023 10 27; 20(1):246.
    View in: PubMed
    Score: 0.022
  44. Introduction to A Compendium of Strategies to Prevent Healthcare-Associated Infections In Acute-Care Hospitals: 2022 Updates. Infect Control Hosp Epidemiol. 2023 10; 44(10):1533-1539.
    View in: PubMed
    Score: 0.022
  45. Targeted Vaccine Messaging to Promote COVID-19 Vaccines for Children and Youth. Pediatrics. 2023 06 01; 151(6).
    View in: PubMed
    Score: 0.021
  46. Healthcare-Associated Respiratory Syncytial Virus in Children's Hospitals. J Pediatric Infect Dis Soc. 2023 May 31; 12(5):265-272.
    View in: PubMed
    Score: 0.021
  47. Fecal Microbiota Transplantation for Clostridioides difficile Infection in Immunocompromised Pediatric Patients. J Pediatr Gastroenterol Nutr. 2023 04 01; 76(4):440-446.
    View in: PubMed
    Score: 0.021
  48. Baseline stool toxin concentration is associated with risk of recurrence in children with Clostridioides difficile infection. Infect Control Hosp Epidemiol. 2023 09; 44(9):1403-1409.
    View in: PubMed
    Score: 0.021
  49. Stool Toxin Concentration Does Not Distinguish Clostridioides difficile Infection from Colonization in Children Less Than 3 Years of Age. J Pediatric Infect Dis Soc. 2022 Oct 25; 11(10):454-458.
    View in: PubMed
    Score: 0.020
  50. Factors Associated With Severe Illness in Patients Aged <21 Years Hospitalized for COVID-19. Hosp Pediatr. 2022 09 01; 12(9):760-783.
    View in: PubMed
    Score: 0.020
  51. Clostridioides difficile Infection in Hospitalized Pediatric Patients: Comparisons of Epidemiology, Testing, and Treatment from 2013 to 2019. J Pediatr. 2023 01; 252:111-116.e1.
    View in: PubMed
    Score: 0.020
  52. Association of Diagnostic Stewardship for Blood Cultures in Critically Ill Children With Culture Rates, Antibiotic Use, and Patient Outcomes: Results of the Bright STAR Collaborative. JAMA Pediatr. 2022 07 01; 176(7):690-698.
    View in: PubMed
    Score: 0.020
  53. Severe Hepatitis in Pediatric Coronavirus Disease 2019. J Pediatr Gastroenterol Nutr. 2022 05 01; 74(5):631-635.
    View in: PubMed
    Score: 0.020
  54. COVID-19-Related Submission Priorities From the Journal of the Pediatric Infectious Diseases Society. J Pediatric Infect Dis Soc. 2022 Jan 27; 11(1):1-2.
    View in: PubMed
    Score: 0.019
  55. Characteristics and Clinical Outcomes of Children and Adolescents Aged <18 Years Hospitalized with COVID-19 - Six Hospitals, United States, July-August 2021. MMWR Morb Mortal Wkly Rep. 2021 12 31; 70(5152):1766-1772.
    View in: PubMed
    Score: 0.019
  56. SHEA Pediatric Leadership Council commentary: Supporting well child care during the coronavirus disease 2019 (COVID-19) pandemic with personal protective equipment in the ambulatory setting. Infect Control Hosp Epidemiol. 2021 08; 42(8):985-988.
    View in: PubMed
    Score: 0.018
  57. SHEA Pediatric Leadership Council commentary: Personal protective equipment during care of children with multisystem inflammatory syndrome in children (MIS-C). Infect Control Hosp Epidemiol. 2021 09; 42(9):1108-1110.
    View in: PubMed
    Score: 0.018
  58. SHEA Pediatric Leadership Council commentary: Ambulatory management of neonates born to mothers infected with severe acute respiratory coronavirus virus 2 (SARS-CoV-2). Infect Control Hosp Epidemiol. 2021 09; 42(9):1105-1107.
    View in: PubMed
    Score: 0.018
  59. Prevalence and Characteristics of Non-Beta-Lactam Allergy Labeling at a Children's Hospital. J Pediatric Infect Dis Soc. 2021 05 28; 10(5):702.
    View in: PubMed
    Score: 0.018
  60. Exploration and Ethical Analysis of Open-label Pediatric Vaccine Trials in a Pandemic. Clin Ther. 2021 06; 43(6):e163-e172.
    View in: PubMed
    Score: 0.018
  61. Surveillance Cultures and Infection in 230 Pacemaker and Defibrillator Generator Changes in Pediatric and Adult Congenital Patients. World J Pediatr Congenit Heart Surg. 2021 05; 12(3):331-336.
    View in: PubMed
    Score: 0.018
  62. Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study. Lancet Child Adolesc Health. 2021 03; 5(3):167-177.
    View in: PubMed
    Score: 0.018
  63. Pediatric research priorities in healthcare-associated infections and antimicrobial stewardship. Infect Control Hosp Epidemiol. 2021 05; 42(5):519-522.
    View in: PubMed
    Score: 0.018
  64. Benign course of SARS-CoV-2 infection in a series of pediatric oncology patients. Pediatr Blood Cancer. 2020 09; 67(9):e28504.
    View in: PubMed
    Score: 0.017
  65. Ideal and Actual Impact of Rapid Diagnostic Testing and Antibiotic Stewardship on Antibiotic Prescribing and Clinical Outcomes in Children With Positive Blood Cultures. Pediatr Infect Dis J. 2019 02; 38(2):131-137.
    View in: PubMed
    Score: 0.016
  66. Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2019 01; 68(1):130-143.
    View in: PubMed
    Score: 0.016
  67. Utilizing the electronic health record to construct antibiograms for previously healthy children with urinary tract infections. Infect Control Hosp Epidemiol. 2018 12; 39(12):1473-1475.
    View in: PubMed
    Score: 0.015
  68. Safety and Pharmacokinetic Study of Fidaxomicin in Children With Clostridium difficile-Associated Diarrhea: A Phase 2a Multicenter Clinical Trial. J Pediatric Infect Dis Soc. 2018 Aug 17; 7(3):210-218.
    View in: PubMed
    Score: 0.015
  69. Central venous catheter salvage in children with Staphylococcus aureus central line-associated bloodstream infection. Pediatr Surg Int. 2017 Nov; 33(11):1201-1207.
    View in: PubMed
    Score: 0.014
  70. Optimizing empiric therapy for Gram-negative bloodstream infections in children. J Hosp Infect. 2018 Jun; 99(2):145-147.
    View in: PubMed
    Score: 0.014
  71. Clostridium difficile-Diagnostic and Clinical Challenges. Clin Chem. 2016 Feb; 62(2):310-4.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.